EGFR and KRAS mutations in metastatic lung adenocarcinomas

D Munfus-McCray, S Harada, C Adams, F Askin… - Human pathology, 2011 - Elsevier
In primary lung adenocarcinoma, EGFR and KRAS mutations are found in approximately
10% to 20% and 20% to 30%, respectively. Few studies have investigated these mutations …

EGFR and KRAS mutations in metastatic lung adenocarcinomas

D Munfus-McCray, S Harada, C Adams, F Askin… - Human Pathology, 2011 - infona.pl
In primary lung adenocarcinoma, EGFR and KRAS mutations are found in approximately
10% to 20% and 20% to 30%, respectively. Few studies have investigated these mutations …

[引用][C] EGFR and KRAS mutations in metastatic lung adenocarcinomas

D MUNFUS-MCCRAY, S HARADA… - Human …, 2011 - pascal-francis.inist.fr
EGFR and KRAS mutations in metastatic lung adenocarcinomas CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

EGFR and KRAS mutations in metastatic lung adenocarcinomas

D Munfus-Mccray, S Harada, C Adams… - Human …, 2011 - pure.johnshopkins.edu
In primary lung adenocarcinoma, EGFR and KRAS mutations are found in approximately
10% to 20% and 20% to 30%, respectively. Few studies have investigated these mutations …

EGFR and KRAS mutations in metastatic lung adenocarcinomas

D Munfus-McCray, S Harada, C Adams… - Human …, 2011 - pubmed.ncbi.nlm.nih.gov
In primary lung adenocarcinoma, EGFR and KRAS mutations are found in approximately
10% to 20% and 20% to 30%, respectively. Few studies have investigated these mutations …

[PDF][PDF] EGFR and KRAS mutations in metastatic lung adenocarcinomas☆

D Munfus-McCray, MD Shuko Harada… - Human …, 2011 - academia.edu
In primary lung adenocarcinoma, EGFR and KRAS mutations are found in approximately
10% to 20% and 20% to 30%, respectively. Few studies have investigated these mutations …

EGFR and KRAS mutations in metastatic lung adenocarcinomas.

D Munfus-McCray, S Harada, C Adams, F Askin… - Human …, 2011 - europepmc.org
In primary lung adenocarcinoma, EGFR and KRAS mutations are found in approximately
10% to 20% and 20% to 30%, respectively. Few studies have investigated these mutations …

[引用][C] EGFR and KRAS mutations in metastatic lung adenocarcinomas

D Munfus-McCray, S Harada, C Adams, F Askin… - Human …, 2011 - Elsevier Limited